Adalimumab Biosimilar–Induced Autoimmunity-Related Sweet-Like Neutrophilic Dermatosis. (10th March 2023)

• Record Type: Journal Article
• Authors: Lobato-Berezo, Alejandro; Pujol, Ramon M.; Fernández-Figueras, María Teresa
• Is Part Of: American journal of dermatopathology. Volume 45:Number 3(2023)
• Page Start: 176
• Page End: 179
• Publication Date: 2023-03-10
• Subjects: anti-TNF -- neutrophilic dermatosis -- adalimumab -- biosimilar -- autoimmunity -- Sweet; Skin -- Diseases -- Periodicals; Histology, Pathological -- Periodicals; 616.50705
• DOI: 10.1097/DAD.0000000000002368
• Languages: English
• ISSNs: 0193-1091

Abstract

Abstract: Antitumor necrosis factor therapies have shown to produce a broad range of cutaneous eruptions. We report the case of a patient under adalimumab biosimilar treatment for a punctate inner choroidopathy who developed a cutaneous eruption on sun-exposed areas that showed a diffuse dermal neutrophilic infiltrate consistent with a Sweet-like neutrophilic dermatosis and some features of autoimmunity.